About Amprion
Amprion is a Healthcare company based in Houston (United States) founded in 2006. Assay technology for misfolded proteins in neurodegenerative disorders is developed. It operates on a HealthTech model. Amprion has raised $11.76 million across 9 funding rounds from investors including Lilly, HHS and Foundry. Amprion offers products and services including SAAmplify-αSYN. Its focus areas include Diagnostics and Neurodegenerative Disease Testing. Its legal entity is Amprion Diagnostics.
Company details
Amprion Diagnostics is engaged in developing diagnostic tests for neurodegenerative disorders such as Parkinsons, Lewy body dementia, and Alzheimers. The companys primary offering, SAAmplify-αSYN, is a validated test for detecting pathological α-synuclein in cerebrospinal fluid, providing biological clarity with autopsy-confirmed accuracy. Services are tailored for patients, clinicians, and biopharma partners to improve diagnosis and treatment decisions. Research partnerships are maintained to advance insights into disease biology across healthcare sectors.
- Headquarters Houston, United States
- SectorsHealthcare
- Email••••••••
- Website ampriondx.com
- Social LinkedIn YouTube
- Legal Name Amprion Diagnostics
- Total Equity Funding$11.76M (USD)
in 9 rounds
- InvestorsLilly
& 4 more
Products & Services of Amprion
Amprion offers a comprehensive portfolio of products and services, including SAAmplify-αSYN.
A test detecting pathological α-synuclein in CSF samples.
Apps and channels of Amprion
its YouTube channel AmprionME has 121 subscribers and 30 videos.
Videos from Amprion
The most watched videos on Amprion's YouTube channel, AmprionME (121 subscribers). Click a video to play it here.
More on AmprionME.
Funding Insights of Amprion
Amprion has successfully raised a total of $11.76M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.76M
- Total Rounds 9
- First Round $1.17M
(May 2012)
- Investors Count 5
All 9 funding rounds of Amprion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2026 | Series B | – | – | ||
| Oct 2024 | $6M | Series B | – | Foundry | |
| Sep 2024 | $100,000 | Grant | – | – | |
| Sep 2024 | $5.76M | Series A | – | – | – |
| Apr 2018 | $1.46M | Grant | – | – | |
| Sep 2016 | $2.47M | Grant | – | – | |
| Jun 2016 | $1.29M | Grant | – | – | |
| Sep 2013 | $1.17M | Grant | – | – | |
| May 2012 | $1.17M | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Amprion
Amprion has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Lilly, HHS and Foundry.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| decathloncapital.com | ||||
Scientists are empowered to reduce human suffering through capital and company-building expertise provided by the firm. | 2020 | formationve.com | United States | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | lilly.com | United States | |
| alsnetwork.org | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Amprion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Amprion
18 people are tracked at Amprion (9 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Christy Hui | CMO | Leadership |
Russell Lebovitz | CEO & CoFounder | Leadership |
Luis Concha | Director, Research & Development | Leadership |
Ginger Sedillo | Director of Finance And Operations | Leadership |
Kendal Jensen | Clinical Laboratory Director | Leadership |
Sean McEvoy | VP, Biopharma Partnerships | Leadership |
Shawna Prange | Assoc Director Of Assay Development | Leadership |
Brandt Charters | Chief Commercial Officer | Leadership |
Luis Concha Marambio | Director of Research and Development | Leadership |
Nelson Kha | Lead Clinical Laboratory Scientist | Team |
Claudio Soto | CSO & CoFounder | Team |
Carly Farris | Senior Research Associate | Team |
Yihua Ma | Scientist II | Team |
Bret Holguin, M.S. | Research Associate | Team |
Manuel Medina | Clinical Laboratory Scientist | Team |
Karen MacLeod | EVP, Regulatory & Clinical Operations | Team |
Nelson Kha, CLS, MT(ASCP) | Lead Clinical Laboratory Scientist | Team |
Connor Daley | Manager, Biopharma Services | Team |
Complete people profiles for Amprion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Amprion
3 dated milestones of Amprion across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Amprion is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Series B,.
Web traffic of Amprion
The website of Amprion (ampriondx.com) receives about 3.1K visits a month.
- Monthly visits3.1K
▲ 19.9% vs previous month
Top companies in Neurology
3 companies that operate in the same segment as Amprion (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amprion
Complete news archive for Amprion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amprion
Amprion was founded in 2006 and raised its 1st funding round 6 years after it was founded.
Amprion is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Amprion is a funded company, having raised a total of $11.76M across 9 funding rounds to date. The company's 1st funding round was a Grant of $1.17M, raised on May 2012.
Amprion Diagnostics is engaged in developing diagnostic tests for neurodegenerative disorders such as Parkinsons, Lewy body dementia, and Alzheimers. The companys primary offering, SAAmplify-αSYN, is a validated test for detecting pathological α-synuclein in cerebrospinal fluid, providing biological clarity with autopsy-confirmed accuracy. Services are tailored for patients, clinicians, and biopharma partners to improve diagnosis and treatment decisions. Research partnerships are maintained to advance insights into disease biology across healthcare sectors.
Amprion offers SAAmplify-αSYN.
Amprion operates through Amprion Diagnostics.